Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Puretech Health Plc ADR (PRTC)

Puretech Health Plc ADR (PRTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
This Emerging Market Could Be the Next Big Thing in Biotech Motley Fool - Fri Jul 14, 2023

Medicines to treat the many symptoms of long COVID are in high demand already.

PRTC : 19.52 (-5.31%)
PFE : 28.67 (-0.93%)
ARGX : 547.28 (+0.96%)
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic Business Wire - Thu May 4, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted today that its Founded Entity, Akili, Inc. (Nasdaq: AKLI) (“Akili”),...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
AKLI : 0.4320 (-0.62%)
PureTech Announces Annual Results for Year Ended December 31, 2022 Business Wire - Fri Apr 28, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
BIIB : 190.80 (-1.57%)
KRTX : 329.83 (+0.03%)
VOR : 0.6380 (-8.86%)
AKLI : 0.4320 (-0.62%)
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies Business Wire - Tue Apr 25, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences , a clinical-stage...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID Business Wire - Mon Apr 17, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences, a clinical-stage...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
PureTech Health: Notice of Results Business Wire - Thu Apr 13, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its annual report and financial results on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The report...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million Business Wire - Thu Mar 23, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
RPRX : 28.38 (+0.32%)
PureTech to Present at the Barclays Global Healthcare Conference Business Wire - Wed Mar 1, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD) Business Wire - Mon Feb 27, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Sonde Health , a health technology...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression Business Wire - Tue Feb 14, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC : 19.52 (-5.31%)
PRTC.LN : 141.600 (+0.14%)

Barchart Exclusives

2 High-Yielding Dividend Stocks Set to Benefit from China's Stimulus Barchart - Tue Oct 1, 6:30PM CDT
While China's stimulus is expected to spur its economic growth, metal and mining companies will also benefit from the recovery in China. BHP and RIO look like 2 high-yielding dividend stocks to buy for investors looking to play China's stimulus. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot